The pandemic of respiratory disease caused by the novel coronavirus named SARS-CoV-2,
which emerged at the end of 2019, is still ongoing [1, 2]. Many scientific reports worldwide …

This issue of JACC: Case Reports features 3 papers (1–3), highlighting the challenges
related to clinical suspicion, diagnosis, and management of acute pulmonary embolism in …

Introduction COVID-19 may predispose to both venous and arterial thromboembolism due to
excessive inflammation, hypoxia, immobilisation and diffuse intravascular coagulation …

Background Thrombotic events can increase the COVID-19 associated disease mortality.
The administration of prophylactic anticoagulants had been shown to decrease the …

AIMS OF THE STUDY Many centres have noticed a high number of venous
thromboembolism (VTE) events among critically ill inpatients with COVID-19 pneumonia …

Background Few data are available on the rate and characteristics of thromboembolic
complications in hospitalized patients with COVID-19. Methods We studied consecutive …

Objectives Thrombosis is a common complication of the novel COVID-19. Pre-COVID-19
studies reported racial differences in the risk of developing thrombosis. This study aimed to …

Background Cardiovascular complications, including myocardial infarction, ischemic stroke,
and pulmonary embolism, represent an important source of adverse outcomes in …

A high incidence of thrombosis in hospitalised patients with COVID-19 was identified early
during the pandemic. Accurately quantifying thrombotic risk may assist prognosis and guide …

Background We aimed to identify the prevalence and predictors of venous
thromboembolism (VTE) or mortality in hospitalized coronavirus disease 2019 (COVID-19) …